![]() ![]() Garrigues TM, Martin U, Peris-Ribera JE et al (1991) Dose-dependent absorption and elimination of cefadroxil in man. ![]() From healthy subjects to phase 2 dose ranging in patients. Ĭosson VF, Fuseau E (1999) Mixed effect modeling of sumatriptan pharmacokinetics during drug development: II. Zhou H (2003) Pharmacokinetic strategies in deciphering atypical drug absorption profiles. Papadopoulou V, Kosmidis K, Vlachou M, Macheras P (2006) On the use of the Weibull function for the discernment of drug release mechanisms. Kopelman R (1988) Fractal reaction kinetics. Macheras P, Argyrakis P (1997) Gastrointestinal drug absorption: is it time to consider heterogeneity as well as homogeneity? Pharm Res 14:842–847. Savic RM, Jonker DM, Kerbusch T, Karlsson MO (2007) Implementation of a transit compartment model for describing drug absorption in pharmacokinetic studies. īonate P (2011) Pharmacokinetic-pharmacodynamic modeling and simulation, 2nd edn. Monoexponential model: routine clinical pharmacokinetic data. Sheiner LB, Beal SL (1983) Evaluation of methods for estimating population pharmacokinetic parameters. Biexponential model and experimental pharmacokinetic data. Sheiner LB, Beal SL (1981) Evaluation of methods for estimating population pharmacokinetic parameters. ![]() ĭokoumetzidis A, Papadopoulou V, Macheras P (2006) Analysis of dissolution data using modified versions of Noyes–Whitney equation and the Weibull function. Sugano K (2021) Lost in modelling and simulation? ADMET DMPK 9:75–109. Sugano K (2012) Biopharmaceutics modeling and simulations: theory, practice, methods, and applications. Lovering EG, McGilveray IJ, McMillan I, Tostowaryk W (1975) Comparative bioavailabilities from truncated blood level curves. Wu D, Tsekouras AA, Macheras P, Kesisoglou F (2022) Physiologically based pharmacokinetic models under the prism of the finite absorption time concept. Tsekouras AA, Macheras P (2022) Columbus’ egg: oral drugs are absorbed in finite time. 30th PAGE meeting Ljubljana 28 June-1 July, 2022 Īlimpertis N, Tsekouras AA, Macheras P (2022) Revising the assessment of bioequivalence in the light of finite absorption time (FAT) concept: the axitinib case. Tsekouras AA, Macheras P (2021) Re-examining digoxin bioavailability after half a century: time for changes in the bioavailability concepts. Macheras P, Tsekouras AA (in press) Revising oral pharmacokinetics, bioavailability and bioequivalence based on the finite absorption time concept. Ĭhryssafidis P, Tsekouras AA, Macheras P (2022) Re-writing oral pharmacokinetics using physiologically based finite time pharmacokinetic (PBFTPK) models. ![]() Ībuhelwa A, Foster D, Upton R (2016) A quantitative review and meta-models of the variability and factors affecting oral drug absorption-part II: gastrointestinal transit time. Ĭhryssafidis P, Tsekouras AA, Macheras P (2021) Revising pharmacokinetics of oral drug absorption: II bioavailability-bioequivalence considerations. Macheras P (2019) On an unphysical hypothesis of Bateman equation and its implications for pharmacokinetics. Macheras P, Chryssafidis P (2020) Revising pharmacokinetics of oral drug absorption: I models based on biopharmaceutical/physiological and finite absorption time concepts. Proc Camb Philos Soc Math Phys Sci 15:423–427 Thieme, Leipzigīateman H (1910) The solution of a system of differential equations occurring in the theory of radioactive transformations. Kinetik der Konzentrationsabläufe in der Kreislaufflüssigkeit. Ioannidis JPA (2012) Why science is not necessarily self-correcting. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |